Movano (NASDAQ:MOVE) Downgraded by Wall Street Zen to “Sell”

Wall Street Zen cut shares of Movano (NASDAQ:MOVE) from a hold rating to a sell rating in a research report released on Sunday.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Movano Stock Down 5.7%

Movano stock opened at $11.77 on Friday. The firm has a market capitalization of $13.42 million, a PE ratio of -1.09 and a beta of 0.80. Movano has a 52 week low of $4.67 and a 52 week high of $54.40. The firm’s 50-day simple moving average is $10.23 and its 200 day simple moving average is $8.52.

Movano (NASDAQ:MOVE) last released its quarterly earnings results on Friday, November 14th. The technology company reported ($4.73) EPS for the quarter, beating the consensus estimate of ($7.00) by $2.27. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%. The business had revenue of $0.08 million for the quarter, compared to analyst estimates of $3.88 million.

Insider Buying and Selling

In other news, CEO John Mastrototaro sold 33,069 shares of the company’s stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $20.80, for a total transaction of $687,835.20. Following the completion of the sale, the chief executive officer directly owned 56,114 shares in the company, valued at $1,167,171.20. This represents a 37.08% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CTO Michael Aaron Leabman sold 6,845 shares of the stock in a transaction on Wednesday, January 14th. The stock was sold at an average price of $6.66, for a total value of $45,587.70. Following the completion of the transaction, the chief technology officer directly owned 22,639 shares in the company, valued at $150,775.74. This trade represents a 23.22% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 94,383 shares of company stock valued at $1,524,933. Insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC acquired a new position in Movano Inc. (NASDAQ:MOVE) during the third quarter, according to the company in its most recent filing with the SEC. The fund acquired 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned approximately 5.94% of Movano at the end of the most recent reporting period. 16.64% of the stock is currently owned by institutional investors.

Key Movano News

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Cooler inflation and stronger jobs data raised bets on future rate cuts, which can support speculative/small‑cap stocks like Movano if investors rotate back into risk assets; this macro tailwind may blunt some selling pressure. Article Title
• Positive Sentiment: Clinical progress in large pharma (e.g., Bristol‑Myers Squibb moving a stroke trial forward) can lift sentiment for healthcare and medtech names broadly; while not directly tied to Movano, positive clinical news can improve sector flows. Article Title
• Neutral Sentiment: Micron’s strong comments and stock strength highlight a bifurcation within tech — large cap semis can rally while smaller tech/health names lag; this divergence helps explain why MOVE can underperform even on otherwise positive tape. Article Title
• Neutral Sentiment: Company/industry governance and scheduling headlines (e.g., shareholder meeting notices from other small issuers) have limited direct impact on Movano but are part of a broader small‑cap news flow backdrop. Article Title
• Negative Sentiment: Broad tech weakness and fresh worries around AI disruption drove a sharper down‑move in U.S. stocks, pressuring small tech/health stocks with weak liquidity — a direct headwind for Movano’s thinly traded shares. Article Title
• Negative Sentiment: Geopolitical/regulatory actions hitting big tech (e.g., Russia blocking WhatsApp) increase market uncertainty and can amplify risk‑off flows that tend to hit small, speculative names harder. Article Title

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.